Download full text
(352.8Kb)
Citation Suggestion
Please use the following Persistent Identifier (PID) to cite this document:
https://nbn-resolving.org/urn:nbn:de:0168-ssoar-239489
Exports for your reference manager
Pricing and Patents of HIV/AIDS Drugs in Developing Countries
[journal article]
Abstract This paper provides empirical evidence on the impact of patents on drug prices across developing countries. It uses sales data on HIV/AIDS drugs in a sample of 34 low and middle-income countries between 1995 and mid-2000. The main findings are that patents do shift drug prices up, that drug prices a... view more
This paper provides empirical evidence on the impact of patents on drug prices across developing countries. It uses sales data on HIV/AIDS drugs in a sample of 34 low and middle-income countries between 1995 and mid-2000. The main findings are that patents do shift drug prices up, that drug prices are correlated to per capita income levels, and that drug firms follow a skimming strategy when pricing new HIV/AIDS drugs. That is, there is across country and intertemporal price discrimination in the global drug markets.... view less
Document language
English
Publication Year
2007
Page/Pages
p. 505-518
Journal
Applied Economics, 39 (2007) 4
DOI
https://doi.org/10.1080/00036840500438954
Status
Postprint; peer reviewed
Licence
PEER Licence Agreement (applicable only to documents from PEER project)